Molecular descriptors and in silico studies of 4-((5-(decylthio)-4-methyl-4n-1,2,4-triazol-3-yl)methyl)morpholine as a potential drug for the treatment of fungal pathologies.
- DOI
- 10.1016/j.compbiolchem.2024.108206
- Published
- 2024 Dec
- Container
- Computational biology and chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.compbiolchem.2024.108206,
title = {Molecular descriptors and in silico studies of 4-((5-(decylthio)-4-methyl-4n-1,2,4-triazol-3-yl)methyl)morpholine as a potential drug for the treatment of fungal pathologies.},
author = {Myroslava O and Poustforoosh A and Inna B and Parchenko V and Tüzün B and Gutyj B},
year = {2024},
journal = {Computational biology and chemistry},
doi = {10.1016/j.compbiolchem.2024.108206},
url = {https://doi.org/10.1016/j.compbiolchem.2024.108206}
}RIS
TY - JOUR TI - Molecular descriptors and in silico studies of 4-((5-(decylthio)-4-methyl-4n-1,2,4-triazol-3-yl)methyl)morpholine as a potential drug for the treatment of fungal pathologies. AU - Myroslava O AU - Poustforoosh A AU - Inna B AU - Parchenko V AU - Tüzün B AU - Gutyj B PY - 2024 JO - Computational biology and chemistry DO - 10.1016/j.compbiolchem.2024.108206 UR - https://doi.org/10.1016/j.compbiolchem.2024.108206 ER -
APA
O, M., A, P., B, I., V, P., B, T., & B, G. (2024). Molecular descriptors and in silico studies of 4-((5-(decylthio)-4-methyl-4n-1,2,4-triazol-3-yl)methyl)morpholine as a potential drug for the treatment of fungal pathologies.. Computational biology and chemistry. https://doi.org/10.1016/j.compbiolchem.2024.108206
Source records
- pubmed · retrieved 2026-09-27T15:08:25.704Z